Insights

Why Shares of MannKind Corporation Climbed 10.4% on Monday

What happened

Shares of MannKind Corporation (NASDAQ: MNKD), a biotech company that specializes in finding therapies for endocrine and orphan lung diseases, rose 10.4% on Monday. The stock closed at $3.45 on Friday and opened at that price on Monday. A little after 11 a.m., the stock reached its day’s high of $3.81. It has a 52-week low of $2.49 and a 52-week high of $5.44.

So what

The stock moved on the news regarding a study on Yutrepia, an inhalation powder form of treprostinil being developed by Liquidia (NASDAQ: LQDA). It’s a competitor to MannKind’s newly approved pulmonary arterial hypertension (PAH) therapy associated with interstitial lung disease (PH-ILD), Tyvaso DPI (treprostinil), which MannKind developed in collaboration with United Therapeutics (NASDAQ: UTHR). Liquidia said users preferred using Yutrepia to Tyvaso, although the frequency of mild side effects from Yutrepia was higher.

It’s also worth noting that Yutrepia cannot be marketed in the United States because of an ongoing lawsuit by United Therapeutics against Liquidia. The lawsuit accuses Liquidia of infringement of three patents related to Tyvaso, which the Food and Drug Administration approved in May.

Now what

With a relatively low stock price, it isn’t unusual to see volatility in the pharmaceutical stock.

Tyvaso DPI is MannKind’s second marketed drug, so it will be interesting to see how well it does in the marketplace. For now, it is the only approved dry-powder inhaled treatment for PAH patients with PH-ILD. The company lost $26 million, or $0.10 per share, in the first quarter. But its revenue for its other approved drug, Afrezza, a man-made form of inhaled insulin, was $9.8 million, up 21% over the same period last year. With a second drug on the market, the company may be about to turn the corner to profitability.

Jim Halley has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Rebate Rewards

Level 2 Rebate

Deposit $2,000 and get $200 Rebate
$ 200 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $2,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $200 Rebate
Popular

Level 1 Rebate

Deposit $1,000 and get $100 Rebate
$ 100 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $1,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $100 Rebate

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex Securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

EASY QUALIFICATION & LOW ENTRY
NEW CLIENT REBATE OFFER
EARN UP TO $200 CASH REBATE
Act Fast - Promotion Ends In
Click Here To Get Started
EASY QUALIFICATION & LOW ENTRY
NEW CLIENT REBATE OFFER
EARN UP TO $200 CASH REBATE
Act Fast - Promotion Ends In
Click Here For More Info